| Serial Number | 88950318 |
| Word Mark | CYTOVALE |
| Filing Date | Friday, June 5, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, December 11, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 14, 2021 |
| Goods and Services | medical services; medical treatment of sepsis, cancer and immune-mediated diseases; medical analysis services in the fields of cytometry, oncology, and hematology |
| Goods and Services | medical diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes, medical diagnostic apparatus for analyzing gene expression tests using bioinformatics and machine learning algorithms, medical diagnostic apparatus for analyzing gene expression tests, gene expression profiling assays, genetic information, protein biomarkers, clinical data and/or demographic information to aid treatment decisions; sample preparation devices in the nature of lyse wash assistant being automated sample preparation instruments capable of lysing, washing, mixing, and fixing samples that are then ready for analysis on a flow cytometer TQ-prep workstations for standardizing whole blood lysis for flow cytometric analysis and related recorded data management software sold as a unit; diagnostic test apparatus for medical use for analysis of gene expression, protein expression, metabolite expression, inflammation, immune- suppression, immune disorders; medical and diagnostic apparatus for medical use in analysis of gene expression tests, analysis of gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing clinical data, and/or analyzing demographic information; point of care medical devices, namely, polymerase chain reaction (pcr) testing equipment for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders; medical testing kits for cancer and other immune-mediated conditions; apparatus for diagnostic purposes, namely, medical diagnostic apparatus for testing for cancer and other immune-mediated conditions in the fields of oncology and hematology; ultraviolet visible and near infrared fluorescence analyzers for medical use and components therefor; imaging platforms, namely, medical imaging apparatus for imaging and analysis of cells and cell organelles, molecular diagnostics and imaging cytometry for medical use; medical apparatuses for the examination and analysis of proteins, peptides, antibodies and molecules for medical diagnostic use and components therefor; diagnostic apparatus for medical use, namely, computed tomography scanners, fluorescent microscope systems comprised of optical detection modalities, magnification objective for use in performing fluorescent antibody technique analysis and fluorescent protein technique analysis, automatic cell sorting systems comprised of single-cell analysis, optical detection modalities, electrical detection modalities, mechanical detection modalities for use in flow cytometry analysis and in fluorescence activated cell sorting; flow cytometers |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 29, 2020 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 29, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cytovale Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94134 |
| Party Name | Cytovale Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94134 |
| Event Date | Event Description |
| Tuesday, June 9, 2020 | NEW APPLICATION ENTERED |
| Monday, June 29, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, September 9, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, September 15, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 15, 2020 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 15, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 16, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 16, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, September 16, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, February 11, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 11, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, February 12, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, February 20, 2021 | FINAL REFUSAL WRITTEN |
| Saturday, February 20, 2021 | FINAL REFUSAL E-MAILED |
| Saturday, February 20, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, August 12, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, August 12, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 12, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 12, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, August 12, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, August 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, August 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, August 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 14, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 9, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, May 2, 2022 | TEAS REQUEST TO DIVIDE RECEIVED |
| Monday, May 2, 2022 | DIVISIONAL REQUEST RECEIVED |
| Monday, May 9, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, May 9, 2022 | SOU EXTENSION 1 FILED |
| Saturday, May 14, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, May 19, 2022 | DIVISIONAL PROCESSING COMPLETE |
| Thursday, May 19, 2022 | SOU EXTENSION 1 GRANTED |
| Friday, May 20, 2022 | CORRECTED NOA E-MAILED |
| Friday, May 20, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, November 2, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, November 2, 2022 | SOU EXTENSION 2 FILED |
| Friday, November 4, 2022 | SOU EXTENSION 2 GRANTED |
| Saturday, November 5, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, January 17, 2023 | ASSIGNED TO EXAMINER |
| Monday, May 8, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, May 8, 2023 | SOU EXTENSION 3 FILED |
| Monday, May 8, 2023 | SOU EXTENSION 3 GRANTED |
| Wednesday, May 10, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, December 11, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, December 11, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |